Variant report
Variant | esv3393385 |
---|---|
Chromosome Location | chr9:12845352-12846600 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188106998 | chr9:12845357-12845358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs552764253 | chr9:12845390-12845391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs192643879 | chr9:12845405-12845406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569463973 | chr9:12845444-12845445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs149551573 | chr9:12845459-12845460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs554345071 | chr9:12845462-12845463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs533621806 | chr9:12845488-12845489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184436184 | chr9:12845531-12845532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550434614 | chr9:12845585-12845586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs398010323 | chr9:12845635-12845636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs533521282 | chr9:12845661-12845662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549964380 | chr9:12845691-12845692 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs371640034 | chr9:12845723-12845724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs373286146 | chr9:12845725-12845726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs188912498 | chr9:12845733-12845734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576679518 | chr9:12845785-12845786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs192532598 | chr9:12845860-12845861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs34105954 | chr9:12845918-12845919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs397894501 | chr9:12845920-12845921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs577345569 | chr9:12845940-12845941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs12553380 | chr9:12845986-12845987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs13287898 | chr9:12846004-12846005 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs16923061 | chr9:12846053-12846054 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs371454330 | chr9:12846059-12846060 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs635655 | chr9:12846077-12846078 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs530232224 | chr9:12846092-12846093 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs546628312 | chr9:12846159-12846160 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs560492683 | chr9:12846245-12846246 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs143232215 | chr9:12846249-12846250 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs7867037 | chr9:12846250-12846251 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs184182916 | chr9:12846257-12846258 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs569597904 | chr9:12846291-12846292 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs10491740 | chr9:12846310-12846311 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs484901 | chr9:12846345-12846346 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs188929656 | chr9:12846359-12846360 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs533889741 | chr9:12846375-12846376 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs370449832 | chr9:12846394-12846395 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs181678329 | chr9:12846429-12846430 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs570107133 | chr9:12846447-12846448 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs483855 | chr9:12846491-12846492 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs142027175 | chr9:12846498-12846499 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs184826663 | chr9:12846516-12846517 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs189715885 | chr9:12846521-12846522 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs180790801 | chr9:12846533-12846534 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs375120166 | chr9:12846579-12846580 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21611746 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:12844600-12849400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr9:12846000-12846600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr9:12846000-12846800 | Enhancers | NHDF-Ad | bronchial |
4 | chr9:12846200-12846800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr9:12846200-12847000 | Enhancers | Fetal Intestine Large | intestine |
6 | chr9:12846200-12849800 | Weak transcription | Colon Smooth Muscle | Colon |
7 | chr9:12846600-12847600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |